Longitudinal changes in vibration-controlled transient elastography in pediatric fatty liver disease
Katherine F Sweeny1, Citlali Aguilera-Rico1, Christina Chan2
1Department of Medicine, Boston Children's Hospital Division of Gastroenterology, Hepatology and Nutrition, Boston, Massachusetts, USA.
Objectives:
There is a lack of research describing changes in vibration-controlled transient elastography (VCTE) parameters in pediatric metabolic dysfunction-associated steatotic liver disease (MASLD). We hypothesized that VCTE measurements would be positively associated with changes in anthropomorphic and biochemical parameters in pediatric MASLD over time, making VCTE a useful tool to monitor MASLD in children.
Methods:
This was a retrospective chart review of children under 18 with MASLD evaluated at Boston Children's Hospital from 2015 to 2023. Demographic, biochemical, and anthropometric data were collected.
Results:
The cohort consisted of 336 children (72.8% male), 192 of which were less than 18 and had two or more VCTE exams, with median age 12.0 (interquartile range [IQR] 10.0-14.0) years. The mean time between VCTE exams was 16.8 months (standard deviation [SD] 11.1). Based on a linear mixed effects model, a unit increase in body mass index (BMI) z-score was associated with a 1.02 kPa increase in liver stiffness measurement (LSM) (p = 0.012). Follow-up time was statistically significantly associated with increasing liver stiffness (p = 0.015) after controlling for baseline age and BMI z-score. For controlled attenuation parameter (CAP), the linear mixed effects model demonstrated a unit increase in BMI z-score was associated with an 88.22 dB/m increase (p < 0.001).
Conclusions:
This is the first study to describe changes in VCTE parameters over time in children with MASLD. Changes in BMI were positively associated with changes in LSM and CAP. VCTE can be an effective tool to monitor changes in disease status over time in pediatric MASLD.
